Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Prograf

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Prograf was produced by Astellas.

Astellas: Ten years young

Astellas: Ten years young

diff. Alongside these launches the company has been moving into the oncology arena, adding to its legacy interest in urology from Yamanouchi and Fujisawa, and transplantation, where it has Prograf (tacrolimus)

Research units to close as Astellas restructures

Research units to close as Astellas restructures For fiscal 2012, revenues grew a little under 4 per cent to 1, 000bn yen - driven by immunosupressant Prograf (tacrolimus), Vesicare (solifenacin succinate) for overactive bladder and recently-launched prostate cancer

The Re-Launch of ADVAGRAF

Astellas Transplant in association with Kane &Finkel Healthcare. ADVAGRAF launched in the EU in 2007 as the convenient, once-daily formulation of the cornerstone immunosuppressant PROGRAF. ... To build on and secure a dominant position in the market,

Lupus – a 'great imitator'

Immunosuppressants such as mycophenolate mofetil (CellCept, Roche) and tacrolimus (Prograf, Astellas Pharma) are used to inhibit the body's production of auto-antibodies, which are responsible for the classical symptoms of

Astellas files patent suit against Sandoz

Prograf is currently approved in Canada and elsewhere as an immunosuppressant following organ transplantation. ... Sandoz previously launched a generic version of Prograf in the US August 2009.

1 2 3 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Could formulary intelligence be your brand differentiator?
Proprietary research, and the COVID-19 experience, shows how formulary intelligence can drive competitive advantage at launch...
Lara Meyer
How COVID-19 is accelerating the threat of antimicrobial resistance
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19...
Improve clinical trials through patient journey mapping
Could patient journey mapping be your solution to improving clinical study recruitment and retention? While awareness of clinical studies is low across the population, it’s not the only issue. It’s...

Infographics